Related Experiment Video

Updated: Jul 15, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Design of treatment trials for functional gastrointestinal disorders

S J Veldhuyzen van Zanten1, N J Talley, P Bytzer

  • 1Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders (Rome II), Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada. zanten@is.dal.ca

Gut
|August 24, 1999
PubMed

Insights

Clinical trials for functional gastrointestinal disorders (FGIDs) have design flaws. Developing validated outcome measures is crucial for determining effective FGID therapies.

Area of Science:

  • Gastroenterology
  • Clinical Trial Design
  • Biostatistics

Background:

  • Historically, clinical trials for functional gastrointestinal disorders (FGIDs) have faced significant challenges in design, execution, and analysis.
  • These methodological weaknesses impede the reliable identification of efficacious therapies for FGIDs.
  • A key issue is the lack of validated outcome measures and consensus on outcome assessment among stakeholders.

Purpose of the Study:

  • To provide guidelines for the fundamental structure of intervention studies in FGIDs.
  • To address the critical need for improved methodological standards in FGID clinical trials.
  • To highlight the ongoing efforts in developing validated outcome measures for FGIDs.

Main Methods:

  • The report advocates for the randomized, controlled trial with parallel groups as the preferred design.
  • It outlines essential components for the architecture of FGID intervention studies.
  • The focus is on establishing robust methodologies for clinical trial evaluation.

Main Results:

  • The study identifies significant weaknesses in past FGID trial design, execution, and data analysis.
  • It emphasizes the absence of validated outcome measures as a major limitation.
  • The need for consensus on outcome measurement is highlighted.

Conclusions:

  • Improved trial design and validated outcome measures are essential for advancing FGID therapeutics.
  • The randomized, controlled trial with parallel groups is recommended for future FGID studies.
  • Further research into design issues is necessary to establish evidence-based recommendations for FGID clinical trials.

More Related Videos

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Using An In Vitro Tissue Perfusion System to Detect the Functional Activities of Isolated Intestinal Tubes in Real Time06:01

Using An In Vitro Tissue Perfusion System to Detect the Functional Activities of Isolated Intestinal Tubes in Real Time

Published on: July 26, 2024

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...